Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 4, 2002, Pages 379-391

  Engelson, Ellen S ^a   Glesby, Marshall J ^a   Mendez, Douglas ^a   Albu, Jeanine B ^a   Wang, Jack ^a   Heymsfield, Steven B ^a   Kotler, Donald P ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Body composition; Clinical trials; Glucose tolerance; Growth hormone; HIV; Lipids; Lipodystrophy; Quality of life

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTHRALGIA; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CARCINOGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID BLOOD LEVEL; LIPID STORAGE; LIPODYSTROPHY; MALE; MUSCLE METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SKELETAL MUSCLE; SUBCUTANEOUS FAT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036682588     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200208010-00002     Document Type: Article

References (52)

1. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors
2. Visceral abdominal-fat accumulation associated with use of indinavir
3. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole body magnetic resonance imaging
4. "Buffalo hump" in men with HIV-1 infection
5. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)
6. Benign symmetric lipomatosis associated with protease inhibitors
7. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
8. Metabolic implications of body fat distribution
9. Pathogenesis of the insulin resistance syndrome (Syndrome X)
10. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 Year follow up of participants in the study of men born in 1913
11. Abdominal obesity and the development of noninsulin dependent diabetes mellitus
12. Action of growth hormone in adipose tissue
13. The regulation of adipose tissue distribution in humans
14. Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: The effect of growth hormone replacement and a comparison with control subject
15. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men
16. Body composition and tissue distribution in growth hormone deficient adults before and after growth hormone treatment
17. Growth hormone treatment of abdominally obese men reduces abdominal mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
18. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults
19. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection
20. Recombinant human growth hormone in patients with HIV-associated wasting: A randomìzed, placebo-controlled trial
21. Assessment of growth hormone physiology in the HIV lipodystrophy syndrome
22. Recombinant human growth hormone improves truncal adiposity and 'buffalo humps' in HIV-positive patients on HAART
23. Reversal of protease inhibitor-related visceral abdominal fat accumulation with recombinant human growth hormone
24. Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV
25. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation
26. Dual photon absorptiometry: Accuracy of bone mineral and soft tissue mass measurements in vivo
27. Human body composition: Advances in models and methods
28. Imaging technique of body composition. Advantages of measurement and new uses
29. Magnetic resonance imaging provides new insights into the characterization of adipose and lean tissue distribution
30. Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men
31. Weight loss in postmenopausal obesity: No adverse alterations in body composition and protein metabolism
32. Quantification of adipose tissue by MRI: Relationship with anthropometric variables
33. Insulin sensitivity indices obtained from oral glucose tolerance testing
34. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
35. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
36. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups
37. A health questionnaire using 30 items from the Medical Outcomes Study
38. Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study instrument
39. Health-related quality of life in HIV-infected women: Evidence for the reliability, validity, and responsiveness of the Medical Outcomes Study Short-form 20
40. Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires
41. HIV illness, social support, sense of coherence, and psychosocial well-being in a sample of help-seeking adults
42. The Brief Symptom Inventory: An introductory report
43. The satisfaction with life scale
44. Abstract of the Life Distress Inventory
45. The Life Distress Inventory: A psychometric examination
46. Analysis of incomplete multivariate analysis
47. Clinical practice recommendations 2000
48. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
49. Effects of growth hormone treatment on visceral adipose tissue
50. Severe premature coronary artery disease with protease inhibitors
51. Coronary artery disease and human immunodeficiency virus infection